With yet a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.
Assessing Patient Fitness for Transplant in Multiple Myeloma
While high-dose chemotherapy and autologous hematopoietic cell transplantation (HCT) can deepen remissions and improve outcomes for multiple myeloma, these treatments come with significant risks, particularly
November 19, 2024